SEC 13F Intelligence

Burrage Capital Management LLC / AIMT

Burrage Capital Management LLC’s Aimmune Therapeutics Inc Position

Does Burrage Capital Management LLC own Aimmune Therapeutics Inc (AIMT)? Not currently — the last reported position was 332.5K shares worth $11M in Q3 2020; the fund’s latest 13F (Q3 2021) no longer reports it.

Position Value
$11M
Q3 2020
Shares
332.5K
% of Portfolio
+9.04%
Quarters Held
3
position exited

Position History AIMT

Reported value by quarter
Q1 ’20: $2MQ1 ’20Q2 ’20: $6MQ2 ’20Q3 ’20: $11MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2020332.5K$11M+9.04%
Q2 2020332.5K$6M+3.89%
Q1 2020112.5K$2M+1.58%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Burrage Capital Management LLC’s full portfolio or all institutional holders of AIMT.